Early initiation of SGLT2 inhibitors within guideline-directed medical therapy and outcomes in newly diagnosed heart failure patients (vol. 25, 879, 2025)

dc.contributor.author	Esteban-Fernández, Alberto
dc.contributor.author	López-Fernández, Silvia
dc.contributor.author	Pastor-Pérez, Francisco-José
dc.contributor.author	Pérez-Rivera, José-Angel
dc.contributor.author	Bonilla-Palomas, Juan-Luis
dc.contributor.author	Cobo-Marcos, Marta
dc.contributor.author	García-Pinilla, José-Manuel
dc.contributor.author	Almenar-Bonet, Luis
dc.contributor.author	Fluvia-Brugues, Paula
dc.contributor.author	Bermúdez-Jiménez, Francisco-J
dc.contributor.author	Goena-Vives, Cristina
dc.contributor.author	López-López, Andrea
dc.contributor.author	Gómez-Otero, Inés
dc.contributor.author	TIDY-HF-researchers,
dc.date.accessioned	2026-08-03T10:26:50Z
dc.date.available	2026-08-03T10:26:50Z
dc.date.issued	2026-02-05
dc.identifier.issn	1471-2261
dc.identifier.uri	https://sms.carm.es/ricsmur/handle/123456789/27151
dc.language.iso	eng
dc.publisher	SPRINGER
dc.rights	Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional
dc.rights.uri	https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es	*
dc.title	Early initiation of SGLT2 inhibitors within guideline-directed medical therapy and outcomes in newly diagnosed heart failure patients (vol. 25, 879, 2025)
dc.type	info:eu-repo/semantics/article
dc.identifier.pmid	41645072
dc.relation.publisherversion	https://link.springer.com/10.1186/s12872-026-05548-8
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.identifier.doi	10.1186/s12872-026-05548-8
dc.journal.title	BMC CARDIOVASCULAR DISORDERS